Your shopping cart is currently empty

ZNL0325 is a covalent probe based on pyrazolo[1,2-a]pyrimidine that demonstrates an alternative binding mode for kinases, where the C3 position is reversed facing the ribose-binding pocket. ZNL0325 and its analogs feature an acrylamide side chain at the C3 position, capable of forming covalent bonds with various kinases possessing cysteine at the αD-1 position, including BTK, EGFR, BLK, and JAK3.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | ZNL0325 is a covalent probe based on pyrazolo[1,2-a]pyrimidine that demonstrates an alternative binding mode for kinases, where the C3 position is reversed facing the ribose-binding pocket. ZNL0325 and its analogs feature an acrylamide side chain at the C3 position, capable of forming covalent bonds with various kinases possessing cysteine at the αD-1 position, including BTK, EGFR, BLK, and JAK3. |
| Synonyms | ZNL-0325, ZNL 0325 |
| Molecular Weight | 316.36 |
| Formula | C15H20N6O2 |
| Smiles | CC(C)(C)N1C2=NC=NC(N)=C2C(OC3CN(C(C=C)=O)C3)=N1 |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.